Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells

被引:64
作者
Corotchi, Maria Cristina [1 ]
Popa, Mirel Adrian [1 ]
Remes, Anca [1 ]
Sima, Livia Elena [2 ]
Gussi, Ilinca [3 ]
Plesu, Marilena Lupu [1 ]
机构
[1] Nicolae Simionescu Romanian Acad, Inst Cellular Biol & Pathol, Dept Regenerat Med, Angiogenesis & Cardiovasc Remodeling Grp, Bucharest 050568, Romania
[2] Romanian Acad, Inst Biochem, Dept Mol Cell Biol, Bucharest 060031, Romania
[3] Clin Hosp Dr Ioan Cantacuzino, Dept Obstet & Gynecol, Bucharest 020000, Romania
关键词
Wharton's jelly; Mesenchymal stem cells; Xeno-free medium; Plasticity; Endothelial differentiation; HUMAN UMBILICAL-CORD; VASCULAR ENDOTHELIAL-CELLS; STROMAL CELLS; IN-VITRO; OSTEOGENIC DIFFERENTIATION; BONE-MARROW; CELLULAR-THERAPY; ADIPOSE-TISSUE; ANGIOGENESIS; INVOLVEMENT;
D O I
10.1186/scrt232
中图分类号
Q813 [细胞工程];
学科分类号
100113 [医学细胞生物学];
摘要
Introduction: Human Wharton's jelly (WJ) has become a preferred source of mesenchymal stem cells (MSCs) whose clinical applications are limited by the use of adequate xeno-free (XF), in vitro manipulation conditions. Therefore, the objective of our study was to characterize WJ-derived MSCs (WJ-MSCs), isolated by different methods and cultured in a commercially available, MSC XF medium, not least of all by investigating their endothelial differentiation capacity. Methods: WJ explants and enzymatically dissociated WJ cells were cultured in a defined, XF medium for MSCs. Adherent cells at passages 2 and 5 were characterized as MSCs by flow cytometry, MTT, real-time quantitative reverse transcription PCR, and functional multipotent differentiation assays. The endothelial differentiation capacity of MSCs isolated and expanded until passage 2 in the MSC XF medium, and then subcultured for five passages in a commercially available endothelial growth medium (group A), was assessed over serial passages, as compared to adherent WJ-derived cells isolated and expanded for five consecutive passages in the endothelial medium (group B). Results: The MSC phenotype of WJ explant-and pellet-derived cells, isolated and expanded in the MSC XF medium, was proven based on the expression of CD44/CD73/CD90/CD105 surface markers and osteo-/adipo-/chondrogenic multipotent differentiation potential, which differed according to the isolation method and/or passage number. Upon exposure to endothelial differentiation cues, cells belonging to group A did not exhibit endothelial cell characteristics over serial passages; by contrast, WJ pellet-derived cells belonging to group B expressed endothelial characteristics at gene, protein and functional levels, potentially due to culture conditions favoring the isolation of other stem/progenitor cell types than MSCs, able to give rise to an endothelial progeny. Conclusions: The use of defined, MSC XF media for isolation and expansion of human WJ-MSCs is a prerequisite for the establishment of their real endothelial differentiation capacity, as candidates for clinical therapy applications. Thus, the standardization of WJ-MSCs isolation and culture expansion techniques in defined, MSC XF media, for their accurate characterization, would be a priority in the stem cell research field.
引用
收藏
页数:16
相关论文
共 68 条
[1]
Abu Kasim NH, 2012, J TISSUE ENGREGEN ME
[2]
Transdifferentiation Potentiality of Human Wharton's Jelly Stem Cells Towards Vascular Endothelial Cells [J].
Alaminos, Miguel ;
Perez-Koehler, Barbara ;
Garzon, Ingrid ;
Garcia-Honduvilla, Natalio ;
Romer, Beatriz ;
Campos, Antonio ;
Bujan, Julia .
JOURNAL OF CELLULAR PHYSIOLOGY, 2010, 223 (03) :640-647
[3]
Engineered adipose tissue from human mesenchymal stem cells maintains predefined shape and dimension: Implications in soft tissue augmentation and reconstruction [J].
Alhadlaq, A ;
Tang, M ;
Mao, JJ .
TISSUE ENGINEERING, 2005, 11 (3-4) :556-566
[4]
Wharton's Jelly Mesenchymal Stem Cells as Candidates for Beta Cells Regeneration: Extending the Differentiative and Immunomodulatory Benefits of Adult Mesenchymal Stem Cells for the Treatment of Type 1 Diabetes [J].
Anzalone, Rita ;
Lo Iacono, Melania ;
Loria, Tiziana ;
Di Stefano, Antonino ;
Giannuzzi, Pantaleo ;
Farina, Felicia ;
La Rocca, Giampiero .
STEM CELL REVIEWS AND REPORTS, 2011, 7 (02) :342-363
[5]
New Emerging Potentials for Human Wharton's Jelly Mesenchymal Stem Cells: Immunological Features and Hepatocyte-Like Differentiative Capacity [J].
Anzalone, Rita ;
Lo Iacono, Melania ;
Corrao, Simona ;
Magno, Francesca ;
Loria, Tiziana ;
Cappello, Francesco ;
Zummo, Giovanni ;
Farina, Felicia ;
La Rocca, Giampiero .
STEM CELLS AND DEVELOPMENT, 2010, 19 (04) :423-438
[6]
Batsali AK, 2013, CURR STEM CELL RES T, V8, P144
[7]
The Therapeutic Potential, Challenges and Future Clinical Directions of Stem Cells from the Wharton's Jelly of the Human Umbilical Cord [J].
Bongso, Ariff ;
Fong, Chui-Yee .
STEM CELL REVIEWS AND REPORTS, 2013, 9 (02) :226-240
[8]
Concise review: Human umbilical cord stroma with regard to the source of fetus-derived stem cells [J].
Can, Alp ;
Karahuseyinoglu, Sercin .
STEM CELLS, 2007, 25 (11) :2886-2895
[9]
Involvement of endothelial CD44 during in vivo angiogenesis [J].
Cao, Gaoyuan ;
Savani, Rashmin C. ;
Fehrenbach, Melane ;
Lyons, Chris ;
Zhang, Lin ;
Coukos, George ;
DeLisser, Horace M. .
AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (01) :325-336
[10]
Chan RW, 2009, TISSUE ENG PT A, V15, P3537, DOI [10.1089/ten.tea.2009.0064, 10.1089/ten.TEA.2009.0064]